Demystifying NewtekOne: Insights From 4 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Recent analyst reviews of NewtekOne (NASDAQ:NEWT) show a mix of ratings, with a shift towards a more cautious outlook. The average 12-month price target has been lowered to $14.5, indicating a 10.77% decrease from the previous target of $16.25. Analysts from firms like Keefe, Bruyette & Woods, Piper Sandler, and B. Riley Securities have adjusted their price targets and ratings, reflecting changes in market conditions and NewtekOne's performance. Despite the market cap being below industry average, NewtekOne has shown significant revenue growth, a high net margin, and strong ROE and ROA, but concerns about its high debt-to-equity ratio persist.
March 20, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NewtekOne's mixed analyst ratings and lowered price targets reflect a cautious market outlook, despite strong revenue growth and financial health indicators. The high debt-to-equity ratio is a concern.
The adjustment in analyst ratings and price targets for NEWT reflects a nuanced view of the company's prospects. While the company's revenue growth, net margin, ROE, and ROA are positive indicators, the high debt-to-equity ratio is a significant concern that could impact investor sentiment and stock performance in the short term. The mixed ratings suggest that analysts are recognizing both the strengths and potential risks associated with NewtekOne, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100